Fact CheckerSign in

NCT04504422Completed

tDCS for Dual-task Performance in Patients With PD

Transcranial Direct Current Stimulation to Improve Dual-task Performance in Idiopathic Parkinson's Disease: A Prospective, Single-center, Double-blind, Explorative Clinical Trial

Source: ClinicalTrials.gov · Last updated 20 Feb 2024

Brief summary (registry, in English)

The purpose of this study is to investigate the optimal stimulation location of transcranial direct current stimulation to improve the dual-task performance in patients with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
5 Aug 2020
Start date
5 Nov 2020
Primary completion date
13 Feb 2024
Lead sponsor
Seoul National University Hospital
NCT number
NCT04504422

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 5 Nov 2020 to the primary completion date, 13 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Plan to adjust medication at the time of screening

Other illness

  • History of seizure
  • Metallic implants, such as cardiac pacemaker or an artificial cochlea
  • Parkinson's disease dementia; cut-off is \< 7 of Korean-Montreal Cognitive Assessment for illiterate patients, \< 13 for those educated for 0.5-3 years, \< 16 for 4-6 years of education, \< 19 for 7-9 years of education, and \< 20 for 10 or more years of education.
  • Sensory abnormalities of the lower extremities, other neurological or orthopedic disease affecting lower extremities, or severe cardiovascular diseases
  • Vestibular disease or paroxysmal vertigo

Other

  • Patients with inflammation, burns, or wounds in the stimulation area
  • Severe dyskinesia or severe on-off phenomenon
  • Pregnant or lactating patients
  • Other comorbidities that make it difficult to participate in this study

Who the study is looking for

  • Clinically diagnosed as idiopathic Parkinson's disease
  • modified Hoehn \& Yahr stage 2, 2.5, or 3

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.